Amrik Singh is an immunology fellow at Cell Signaling Technology (CST). A PhD level biochemist trained at Boston University Medical Center and Beth Israel Deaconess Medical Center, his role at CST involves helping to develop and manage the adoptive cell therapy product portfolio, with a specific interest in developing antibodies and assays to characterize CAR T cells.